ONC201

Overview

ONC201 is a first in class anti tumor drug that can work by producing stress chemicals in the cancer cell and blocking it from growing and dividing.

SparkCures ID 229
Developed By Oncoceutics, Inc.
Generic Name ONC201

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this treatment.